Novak Djokovic holds an 80% stake in a biotech firm that is developing a COVID-19 treatment, QuantBioRes CEO Ivan Loncarevic said to Reuters.
Djokovic made the acquisition in June 2020, but Loncarevic did not reveal how much he invested. Per the outlet, Djokovic holds 40.8% while his wife, Jelena, owns 39.2% of the company. Loncarevic stressed to Reuters that QuantBioRes is working on developing a treatment, not a vaccine, for COVID-19.
The 20-time major singles champion made global headlines recently after his COVID-19 controversy and visa battle ahead of the Australian Open, which resulted in his deportation. The Australian government had revoked his visa from the country for the second time just days before three federal court judges unanimously dismissed Djokovic’s application to overturn the immigration minister's decision.
